NEW ORLEANS – A North Carolina woman alleges her late husband suffered injuries after taking Xarelto.
Betty Moses, individually and as administrator of the estate of Larry Moses, filed a complaint on April 4 in the U.S. District Court for the Eastern District of Louisiana against Jansen Research & Development LLC, Jansen Ortho LLL, Jansen Pharmaceuticals Inc., Johnson & Johnson Co., Bayer Pharma AG, Bayer Corp., Bayer Healthcare Pharmaceuticals Inc., Bayer Healthcare AG, Bayer AG, et al., citing manufacturing defect, design defect, negligence, wrongful death and other counts.
According to the complaint, the plaintiff alleges that between Nov. 6, 2014, and April 14, 2014, Larry Moses directly ingested Xarelto, causing him to suffer severe adverse bleeding. As a direct and proximate result of his use of Xarelto, he suffered serious and dangerous side effects, the suit states. He ultimately died on June 19, 2014, due to injuries, according to the suit.
The plaintiff holds the defendants responsible because the defendants allegedly designed, researched, manufactured, tested, advertised, promoted, marketed distributed and sold Xarelto. They also allegedly failed to properly investigate, research, study and define, fully and adequately, the safety profile of Xarelto; failed to adequately test Xarelto; failed to provide adequate warnings; failed to disclose the need for dose adjustments; failed to disclose the need to twice daily dosing; and failed to provide adequate instructions.
The plaintiff requests a trial by jury and seeks compensation for all economic and non-economic damages, punitive and/or exemplary damages, prejudgment and post-judgment interest, reasonable attorneys’ fees and costs and any further relief as the court deems just and proper. She is represented by Kristian Rasmussen and Mitchell Theodore of Cory Watson PC in Birmingham, Alabama.
U.S. District Court for the Eastern District of Louisiana Case number 2:16-cv-02770